+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

From
Biopharmaceuticals Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biopharmaceuticals Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Shingles Vaccine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Shingles Vaccine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Vaccine Adjuvants Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Vaccine Adjuvants Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Microneedle Flu Vaccine Market - Product Thumbnail Image

Microneedle Flu Vaccine Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Recombinant Vaccines Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Recombinant Vaccines Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
SYNAGIS Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

SYNAGIS Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
ABRYSVO Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

ABRYSVO Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
MEDI8897 Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

MEDI8897 Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Somatotropin - Biosimilar Insight, 2022 - Product Thumbnail Image

Somatotropin - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Ranibizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Ranibizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 150 Pages
  • Global
From
Filgrastim - Biosimilar Insight, 2022 - Product Thumbnail Image

Filgrastim - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Rituximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Rituximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more